Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H30ClFN4O4 |
Molecular Weight | 492.971 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(C=C(Cl)C(N)=C1)C(=O)NCC2CCN(CC[C@H](OC(N)=O)C3=CC=C(F)C=C3)CC2
InChI
InChIKey=KGMMSPVVHZGPHL-NRFANRHFSA-N
InChI=1S/C24H30ClFN4O4/c1-33-22-13-20(27)19(25)12-18(22)23(31)29-14-15-6-9-30(10-7-15)11-8-21(34-24(28)32)16-2-4-17(26)5-3-16/h2-5,12-13,15,21H,6-11,14,27H2,1H3,(H2,28,32)(H,29,31)/t21-/m0/s1
Molecular Formula | C24H30ClFN4O4 |
Molecular Weight | 492.971 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Relenopride (YKP-10811) is a serotonin 4 (5-HT4) receptor agonist that was developed for regulation of gastric motility. It improved antral contractions and accelerated gastric emptying in dogs and had no adverse effects. Phase II clinical trials have investigated the efficacy and safety of relenopride in patients with (chronic and functional) constipation and irritable bowel syndrome (IBD). Relenopride was reported to accelerate gastrointestinal motility and colonic transit and improve bowel functions in patients with functional constipation, compared with placebo.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 21:16:42 UTC 2023
by
admin
on
Fri Dec 15 21:16:42 UTC 2023
|
Record UNII |
SIS5BFO4WL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152177
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
9919
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
CD-75
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
DB12798
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
45275554
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
1221416-43-8
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
300000034311
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
DTXSID50153530
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
SIS5BFO4WL
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL3544975
Created by
admin on Fri Dec 15 21:16:43 UTC 2023 , Edited by admin on Fri Dec 15 21:16:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|